Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Stock Climbs 8 Percent on Positive Q3 Results, Deal Announcement

NEW YORK, Nov. 2 (GenomeWeb News) - Shares in Beckman Coulter were up 8 percent, or $3.94, at $53.44 in mid-afternoon trading after the company announced its third-quarter results and a multi-million-dollar deal this morning.


As GenomeWeb News reported earlier today, Beckman Coulter had a 2-percent increase in third-quarter revenues of $593.4 million and that international sales grew by 3.8 percent. However, net income fell to $36.2 million from $57.2 million year over year.


Separately today, Beckman signed a multi-million dollar deal with Consorta to provide the suburban Chicago based company its chemistry, immunodiagnostics, and automation product lines.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.